StockData
CorMedix Inc. logo

CorMedix Inc. (CRMD) stock

CRMDNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 12, 2026Score 13/30
$4.67−0.15 (-3.11%)

Close on Nov 17, 2026Market cap $364.00MP/E –Yield –

CorMedix total assets

Total assets on the balance sheet at the end of each period.

CorMedix's total assets was $904.05M at Jun 30, 2026. For fiscal 2025 it was $826.14M, up 595.1% from the year before. Over ten years it grew 36.4% a year on average. The highest annual figure on record is $826.14M in fiscal 2025.

Annual total assets

PeriodPeriod endValueChange
FY2025Dec 31, 2025$826.14M+595.1%
FY2024Dec 31, 2024$118.85M+44.8%
FY2023Dec 31, 2023$82.06M+32.3%
FY2022Dec 31, 2022$62.04M-10.0%
FY2021Dec 31, 2021$68.95M+39.8%
FY2020Dec 31, 2020$49.31M+67.3%
FY2019Dec 31, 2019$29.48M+56.6%
FY2018Dec 31, 2018$18.83M+39.9%
FY2017Dec 31, 2017$13.45M-38.6%
FY2016Dec 31, 2016$21.91M-41.0%
FY2015Dec 31, 2015$37.10M+627.8%
FY2014Dec 31, 2014$5.10M+71.8%
FY2013Dec 31, 2013$2.97M+157.3%
FY2012Dec 31, 2012$1.15M-54.9%
FY2011Dec 31, 2011$2.56M-71.1%
FY2010Dec 31, 2010$8.85M–

Quarterly total assets

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026$904.05M+257.9%
Q1 FY2026Mar 31, 2026$815.64M+445.3%
Q4 FY2025Dec 31, 2025$826.14M+595.1%
Q3 FY2025Sep 30, 2025$750.86M+867.8%
Q2 FY2025Jun 30, 2025$252.60M+337.5%
Q1 FY2025Mar 31, 2025$149.58M+119.9%
Q4 FY2024Dec 31, 2024$118.85M+44.8%
Q3 FY2024Sep 30, 2024$77.59M-15.1%
Q2 FY2024Jun 30, 2024$57.73M+1.2%
Q1 FY2024Mar 31, 2024$68.02M+14.8%
Q4 FY2023Dec 31, 2023$82.06M+32.3%
Q3 FY2023Sep 30, 2023$91.43M+47.3%
Q2 FY2023Jun 30, 2023$57.03M-15.8%
Q1 FY2023Mar 31, 2023$59.23M-8.8%
Q4 FY2022Dec 31, 2022$62.04M-10.0%
Q3 FY2022Sep 30, 2022$62.08M-17.7%
Q2 FY2022Jun 30, 2022$67.75M-16.2%
Q1 FY2022Mar 31, 2022$64.93M-22.9%
Q4 FY2021Dec 31, 2021$68.95M+39.8%
Q3 FY2021Sep 30, 2021$75.39M+88.4%
Q2 FY2021Jun 30, 2021$80.86M+233.6%
Q1 FY2021Mar 31, 2021$84.26M+207.5%
Q4 FY2020Dec 31, 2020$49.31M+67.3%
Q3 FY2020Sep 30, 2020$40.02M+18.7%
Q2 FY2020Jun 30, 2020$24.24M-12.1%
Q1 FY2020Mar 31, 2020$27.40M+0.3%
Q4 FY2019Dec 31, 2019$29.48M+56.6%
Q3 FY2019Sep 30, 2019$33.72M+318.9%
Q2 FY2019Jun 30, 2019$27.56M+365.0%
Q1 FY2019Mar 31, 2019$27.31M+184.2%
Q4 FY2018Dec 31, 2018$18.83M+39.9%
Q3 FY2018Sep 30, 2018$8.05M-42.2%
Q2 FY2018Jun 30, 2018$5.93M-72.0%
Q1 FY2018Mar 31, 2018$9.61M-35.7%
Q4 FY2017Dec 31, 2017$13.45M-38.6%
Q3 FY2017Sep 30, 2017$13.93M-51.7%
Q2 FY2017Jun 30, 2017$21.16M–
Q1 FY2017Mar 31, 2017$14.93M–
Q4 FY2016Dec 31, 2016$21.91M–
Q3 FY2016Sep 30, 2016$28.84M–

More CorMedix figures

See a number that looks wrong?